Cardiff Oncology, Inc.

Historical 13F Holders

Symbol
CRDF
CUSIP
14147L108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 14147L108 since 12/18/2024, largest first.

Filer % of Class Filed
Highbridge Capital Management, LLC 13G 5.8% 11/16/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Pfizer Inc 13G/A 3.6% 2/12/2025
Event 12/31/2024
BlackRock, Inc. 13G/A 1.3% 7/27/2026
Event 6/30/2026
Commodore Capital LP 13G/A
0% 8/14/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 76 18.0 M $21.4M
2026 Q2 105 18.7 M $24.2M
2026 Q1 117 24.6 M $39.7M
2025 Q4 110 27.2 M $76.6M
2025 Q3 113 25.2 M $52.1M
2025 Q2 119 28.7 M $90.3M
2025 Q1 120 32.3 M $102M
2024 Q4 118 28.1 M $122M
2024 Q3 85 12.8 M $34.0M
2024 Q2 91 13.1 M $29.1M
2024 Q1 79 8.60 M $45.8M
2023 Q4 56 5.29 M $7.84M
2023 Q3 59 5.46 M $7.58M
2023 Q2 54 5.99 M $8.81M
2023 Q1 56 7.05 M $11.6M
2022 Q4 62 7.70 M $10.8M
2022 Q3 61 7.93 M $12.2M
2022 Q2 70 8.93 M $19.6M
2022 Q1 93 16.5 M $41.0M
2021 Q4 89 22.0 M $132M
2021 Q3 96 21.1 M $141M
2021 Q2 94 26.5 M $176M
2021 Q1 79 24.1 M $223M
2020 Q4 88 26.6 M $479M
2020 Q3 73 18.7 M $266M
2020 Q2 31 4.92 M $24.7M